(Total Views: 106)
Posted On: 10/26/2022 12:11:07 PM
Post# of 27176
$CYCC News Article - Cyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial of Oral Fadraciclib in Patients With Solid Tumors and Lymphoma at ENA 2022 https://marketwirenews.com/news-releases/cycl...23661.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
